Could cause temporary or reversible harm; serious harm is unlikely.
Failed Tablet/Capsule Specification; oversized tablet found in a bottle
| Distributed by / for | SUN PHARMACEUTICAL INDUSTRIES INC |
| NDC | 57664-783-68 |
| Full product label | Clonazepam Orally Disintegrating Tablets, USP, 0.125mg, Rx Only, 60 Tablets, Mfd. by: Sun Pharmaceutical Industries Ltd. Mumbai, India, Dist. by: Sun Pharmaceutical Industries In., Cranbury, NJ 08512, NDC 57664-783-68, packaged in bottles. |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | nationwide within the United States |
| Quantity | 4608 bottles |
| Recall initiated | 2022-06-03 |
| Report date | 2022-06-29 |
| Recall completed | 2023-08-18 |
| Recall number | D-1155-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗